Institutional investors purchased a net $10.5 million shares of SGEN during the quarter ended September 2015 and now own 105.78% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 3.4 Million shares of Seattle Genetics Inc
BAILLIE GIFFORD & CO. Bought 1.9 Million shares of Seattle Genetics Inc
ARTISAN PARTNERS LP Bought 1.5 Million shares of Seattle Genetics Inc